The CardioInsight ECGI system was cleared by the FDA. After 30 years of development and validation in CBAC Director Yoram Rudy’s laboratory, he hopes to see ECGI in clinical use in hospitals, helping to treat cardiac patients.
How a Frankenstein Prototype Ended Up Being Worth $93M (Links to an external site)
While working a Case Western Reserve University, CBAC Director Yoram Rudy, PhD had the idea for a game-changing cardiac monitoring device–a vest filled with more than 200 sensors that could detect the heart’s electrical activity. While standard 12-lead EKGs had become the gold standard for detecting many heart problems, EKGs still can miss cardiac problems because they only probe electrical potential at a limited number of points on the body.
New insights in mechanisms of human cardiac arrhythmias (Links to an external site)
Medtronic acquired CardioInsight Technologies, developer of a clinical noninvasive imaging system, called ECGI, for noninvasive mapping of the electrical activity of the heart and cardiac arrhythmias. The ECGI concept and methodology were developed in Professor Yoram Rudy’s laboratory with support from the NIH – National Heart, Lung and Blood Institute.
First inaugural Cardiac Bioelectricity & Arrhythmia Center (CBAC) Retreat
The CBAC Retreat was a full day of exciting lectures, informal talks and dialogue, and presentations from various CBAC faculty members whose interests range in both research and clinical studies.